Clinical Trial Update: Efficacy and Safety of L19TNF in Previously Treated Patients with Advanced Stage or Metastatic Soft-tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting efficacy and safety results for L19TNF in previously treated patients with advanced or metastatic Soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• L19TNF

Snippet

Sponsor: Philogen S.p.A. | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING